| 000 | 01556 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518012635.0 | ||
| 264 | 0 | _c20190221 | |
| 008 | 201902s 0 0 eng d | ||
| 022 | _a1361-6528 | ||
| 024 | 7 |
_a10.1088/1361-6528/aaf41a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhong, Yuan | |
| 245 | 0 | 0 |
_aTargeted polyethylenimine/(p53 plasmid) nanocomplexes for potential antitumor applications. _h[electronic resource] |
| 260 |
_bNanotechnology _cApr 2019 |
||
| 300 |
_a145601 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aDrug Carriers _xchemistry |
| 650 | 0 | 4 |
_aFluorescein-5-isothiocyanate _xanalogs & derivatives |
| 650 | 0 | 4 |
_aFolate Receptors, GPI-Anchored _xmetabolism |
| 650 | 0 | 4 |
_aFolic Acid _xchemistry |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 |
_aGenetic Vectors _xpharmacology |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNanoconjugates _xchemistry |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 |
_aPlasmids _xgenetics |
| 650 | 0 | 4 |
_aPolyethyleneimine _xchemistry |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 700 | 1 | _aWang, Yi | |
| 700 | 1 | _aLuo, Li | |
| 700 | 1 | _aNurhidayah, Deti | |
| 700 | 1 | _aMaruf, Ali | |
| 700 | 1 | _aGregersen, Hans | |
| 700 | 1 | _aWu, Wei | |
| 700 | 1 | _aWang, Gui-Xue | |
| 773 | 0 |
_tNanotechnology _gvol. 30 _gno. 14 _gp. 145601 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1088/1361-6528/aaf41a _zAvailable from publisher's website |
| 999 |
_c29137375 _d29137375 |
||